The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of ProAgio, an αvβ3 integrin cytotoxin, in patients with previously treated advanced pancreatic cancer and other solid tumors.
 
Nebojsa Skorupan
No Relationships to Disclose
 
Keith Thomas Schmidt
No Relationships to Disclose
 
Eve Koehler
No Relationships to Disclose
 
Min-Jung Lee
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); Propella Therapeutics (Inst); TRACON Pharma (Inst)
 
Zhi-Ren Liu
Employment - ProDa BioTech
Leadership - ProDa BioTech
Stock and Other Ownership Interests - ProDa BioTech
Patents, Royalties, Other Intellectual Property - Georgia State University /ProDa Biotech LLC
Travel, Accommodations, Expenses - ProDa BioTech
 
Christine Alewine
Research Funding - AstraZeneca; HCW Biologics; Minneamrita Therapeutics; ProDa BioTech
Patents, Royalties, Other Intellectual Property - Transgenic mesothelin mice